Grabody Logo (EUIPO, 03/24/2020)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark Grabody was filed as Figurative mark on 03/24/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/14/2020.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Backgrounds, in words or numerals, divided into two, three or four #Letters presenting some other special form of writing #Yellow, gold #Black
| Trademark form | Figurative mark |
| File reference | 018213885 |
| Application date | March 24, 2020 |
| Publication date | April 9, 2020 |
| Entry date | December 14, 2020 |
| Expiration date | March 24, 2030 |
Trademark owner
2nd floor, 16, Daewangpangyo-ro 712beon-gil, Bundang-gu, Seongnam-si,
13488 Gyeonggi-do
KR
13488 Gyeonggi-do
KR
Trademark representatives
Deichmannhaus am Dom, Bahnhofsvorplatz 1
50667 Köln
DE
Objection / Complaint
07/09/2020: Likelihood of confusion
Applicant
Biotalys N.V.
goods and services
5
ophthalmic preparations; ophthalmologic preparations; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary purposes; biotechnological preparations for medical purposes; biological preparations for medical purposes; antibodies for medical purposes; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; anti-cancer preparations; tumor suppressing agents; immunostimulants; pharmaceutical compositions
42
scientific research in the fields of biomedicine; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of technology for biotechnology; biotechnological research; medicine research; laboratory research services relating to pharmaceuticals; research for medicinal products; research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research and development; research on the subject of pharmaceuticals; clinical testing of medicines; clinical studies of medicines; development of cell therapy products; scientific research in the field of pharmacy
ID: 11018213885